P. Altevogt

发表

CD24 expression is a new prognostic marker in breast cancer.

C. Pilarsky, G. Kristiansen, K. Winzer, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Cytoplasmic CD24 Expression in Colorectal Cancer Independently Correlates with Shortened Patient Survival

W. Weichert, G. Kristiansen, J. Bellach, 2005, Clinical Cancer Research.

Vesiclepedia: A Compendium for Extracellular Vesicles with Continuous Community Annotation

P. Altevogt, S. Mathivanan, J. Lötvall, 2012, PLoS biology.

ResearchADAM 10 is expressed in human podocytes and found in urinary vesicles of patients with glomerular kidney diseases

P. Altevogt, J. Pfeilschifter, A. Schramme, 2015 .

Exosomes: from biogenesis and secretion to biological function.

Sascha Keller, Peter Altevogt, Michael P Sanderson, 2006, Immunology letters.

Tumour Biological Aspects of CD24, A Mucin-Like Adhesion Molecule

G. Kristiansen, P. Altevogt, M. Sammar, 2003, Journal of Molecular Histology.

Effects of mutagens on the immunogenicity of murine tumor cells: immunological and biochemical evidence for altered cell surface antigens.

P. Altevogt, V. Schirrmacher, P. von Hoegen, 1985, Cancer research.

alpha5-integrin is crucial for L1CAM-mediated chemoresistance in pancreatic adenocarcinoma.

P. Altevogt, C. Geismann, D. Gast, 2009, International journal of oncology.

Efficient inhibition of intra-peritoneal tumor growth and dissemination of human ovarian carcinoma cells in nude mice by anti-L1-cell adhesion molecule monoclonal antibody treatment.

P. Altevogt, A. Krüger, M. Honer, 2006, Cancer research.

Glycoconjugate expression in adenoid cystic carcinoma of the salivary glands: up‐regulation of L1 predicts fatal prognosis

P. Altevogt, U. Schumacher, T. Löning, 2011, Histopathology.

Blockade of natural killer cell‐mediated lysis by NCAM140 expressed on tumor cells

P. Altevogt, M. Jarahian, F. Momburg, 2007, International journal of cancer.

CD24 polymorphisms in breast cancer: impact on prognosis and risk

Barbara Burwinkel, Petra Seibold, Andreas Schneeweiss, 2013, Breast Cancer Research and Treatment.

CD24 controls Src/STAT3 activity in human tumors

T. Schlange, P. Altevogt, C. Mierke, 2012, Cellular and Molecular Life Sciences.

Expression profile analysis in multiple human tumors identifies L1 (CD171) as a molecular marker for differential diagnosis and targeted therapy.

P. Altevogt, M. Huszar, G. Moldenhauer, 2006, Human pathology.

Recent insights into the role of L1CAM in cancer initiation and progression

P. Altevogt, U. Schumacher, A. Ben-Ze'ev, 2020, International journal of cancer.

L1CAM in human cancer

P. Altevogt, Kai Doberstein, M. Fogel, 2016, International journal of cancer.

The adhesion molecule L1 (CD171) promotes melanoma progression

P. Altevogt, C. Garbe, D. Gast, 2006, International journal of cancer.

Expression and prognostic value of L1-CAM in breast cancer.

F. Feuerhake, P. Altevogt, K. Milde-Langosch, 2009, Oncology reports.

L1 adhesion molecule on human lymphocytes and monocytes: expression and involvement in binding to alpha v beta 3 integrin.

P. Altevogt, P. Möller, J. Kemshead, 1996, European journal of immunology.

Full-Length L1CAM and Not Its Δ2Δ27 Splice Variant Promotes Metastasis through Induction of Gelatinase Expression

P. Altevogt, A. Krüger, J. Ramser, 2011, PloS one.

Expression and prognostic value of L1-CAM in breast cancer

F. Feuerhake, P. Altevogt, K. Milde-Langosch, 2009 .

The role of L1-CAM immunohistochemial staining in the diagnosis of abdominal-pelvic cancer of uncertain primary site in women.

P. Altevogt, M. Huszar, A. Ben‐Arie, 2008, European Journal of Surgical Oncology.

Characterization of CXCL16 and ADAM10 in the normal and transplanted kidney.

P. Altevogt, J. Pfeilschifter, É. Kiss, 2008, Kidney international.

Angiogenic Cytokines Are Antibody Targets During Graft-versus-Leukemia Reactions

P. Altevogt, G. Dranoff, J. Ritz, 2014, Clinical Cancer Research.

CCR5+ Myeloid-Derived Suppressor Cells Are Enriched and Activated in Melanoma Lesions.

J. Utikal, P. Altevogt, V. Umansky, 2018, Cancer research.

Epigenetic regulation of L1CAM in endometrial carcinoma: comparison to cancer–testis (CT-X) antigens

P. Altevogt, H. Fiegl, E. Müller-Holzner, 2013, BMC Cancer.

A role for exosomes in the constitutive and stimulus-induced ectodomain cleavage of L1 and CD44.

P. Altevogt, A. Ludwig, P. Gutwein, 2006, The Biochemical journal.

Mouse CD24 as a signaling molecule for integrin-mediated cell binding: functional and physical association with src-kinases.

P. Altevogt, F. Lang, E. Gulbins, 1997, Biochemical and biophysical research communications.

A novel method for measuring cellular antibody uptake using imaging flow cytometry reveals distinct uptake rates for two different monoclonal antibodies targeting L1.

P. Altevogt, N. Brady, G. Moldenhauer, 2015, Journal of immunological methods.

Lupeol suppresses cisplatin-induced nuclear factor-kappaB activation in head and neck squamous cell carcinoma and inhibits local invasion and nodal metastasis in an orthotopic nude mouse model.

P. Altevogt, J. Myers, X. Guan, 2007, Cancer research.

Copper-67 Radioimmunotherapy and Growth Inhibition by Anti–L1-Cell Adhesion Molecule Monoclonal Antibodies in a Therapy Model of Ovarian Cancer Metastasis

P. Altevogt, S. Ametamey, M. Honer, 2007, Clinical Cancer Research.

Different expression of Lyt differentiation antigens and cell surface glycoproteins by a murine T lymphoma line and its highly metastatic variant

P. Altevogt, V. Schirrmacher, K. Bosslet, 1982, European journal of immunology.

L1CAM in early-stage type I endometrial cancer: results of a large multicenter evaluation.

P. Altevogt, I. Vergote, M. Netzer, 2013, Journal of the National Cancer Institute.

L1CAM malfunction in the nervous system and human carcinomas

P. Altevogt, M. K. Schäfer, Michael K. E. Schäfer, 2010, Cellular and Molecular Life Sciences.

TGF-β1-dependent L1CAM expression has an essential role in macrophage-induced apoptosis resistance and cell migration of human intestinal epithelial cells

P. Altevogt, C. Geismann, S. Sebens, 2013, Oncogene.

Molecular mechanisms of L-selectin-induced co-localization rafts and shedding

P. Altevogt, O. Linderkamp, K. Hexel, 2003 .

Different patterns of lectin binding and cell surface sialylation detected on related high- and low-metastatic tumor lines.

J. Dennis, P. Altevogt, V. Schirrmacher, 1983, Cancer research.

Metastatic potential severely altered by changes in tumor cell adhesiveness and cell-surface sialylation

P. Altevogt, V. Schirrmacher, M. Fogel, 1983, The Journal of experimental medicine.

Enhanced L1CAM expression on pancreatic tumor endothelium mediates selective tumor cell transmigration

M. Koch, P. Altevogt, J. Weitz, 2008, Journal of Molecular Medicine.

A role for the VLA‐4 integrin in the activation of human memory B cells

P. Altevogt, T. Defrance, P. Mondière, 1997, European journal of immunology.

L1 on ovarian carcinoma cells is a binding partner for Neuropilin-1 on mesothelial cells.

P. Altevogt, I. Herr, T. Wenger, 2006, Cancer letters.

The effects of anti‐CD2 antibodies on the differentiation of mouse thymocytes

P. Altevogt, B. Kyewski, M. Owen, 1989, European journal of immunology.

Glucocorticoid-mediated inhibition of chemotherapy in ovarian carcinomas.

P. Altevogt, I. Herr, T. Wenger, 2006, International journal of oncology.

N-glycosylation patterns of HSA/CD24 from different cell lines and brain homogenates: a comparison.

P. Altevogt, B. Schmitz, C. Albach, 2003, Biochimie.

Extracellular Vesicle-Mediated Transfer of Genetic Information between the Hematopoietic System and the Brain in Response to Inflammation

P. Altevogt, K. Plate, H. Sültmann, 2014, Journal of Neuroimmunology.

Biochemical comparison of HLA‐DR molecules derived from autologous human T and B lymphoblasts

P. Altevogt, H. Wigzell, J. Fohlman, 1980, European journal of immunology.

The r Integrin Chain Is a Ligand for r and o ~ 4 B 1 By

P. Altevogt, J. Lohr, M. Hubbe, 2003 .

[Primary structure of class II human histocompatibility antigens. 1st communication. Amino acid sequence of the N-terminal 198 residues of the beta chain of a HLA-Dw2,2;DR2,2-alloantigen (author's transl)].

P. Altevogt, N. Hilschmann, P. Wernet, 1981, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.

Transfer of T Cell Surface Molecules to Dendritic Cells upon CD4+ T Cell Priming Involves Two Distinct Mechanisms1

P. Altevogt, P. Knolle, W. Kolanus, 2008, The Journal of Immunology.

L1 adhesion molecule (CD 171) in development and progression of human malignant melanoma.

P. Altevogt, J. Reichrath, T. Georg, 2003, Cancer letters.

A VH‐Associated Idiotype in Human Anti‐Tetanus Antibodies

P. Altevogt, H. Wigzell, 1983, Scandinavian journal of immunology.

Metalloproteinase-mediated release of the ectodomain of L1 adhesion molecule.

P. Altevogt, P. Gutwein, S. Beer, 1999, Journal of cell science.

Mesothelial Cells in Suspension Expose an Enriched Integrin Repertoire Capable of Capturing Soluble Fibronectin and Laminin

P. Altevogt, T. Barth, P. Möller, 2002, Cell communication & adhesion.

The Neural Cell Adhesion Molecule N-CAM Enhances Ll-dependent Cell-Cell Interactions

P. Altevogt, M. Schachner, Kadmon, 2002 .

Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells

P. Altevogt, B. Sipos, G. Klöppel, 2007, Oncogene.

Procoagulant extracellular vesicles in amniotic fluid

P. Altevogt, A. Spittler, B. Jilma, 2017, Translational research : the journal of laboratory and clinical medicine.

L1 cell adhesion molecule (L1CAM) as a pathogenetic factor in endometriosis.

P. Altevogt, D. Hornung, D. Finas, 2008, Human reproduction.

Heat-stable antigen (mouse CD24) in the brain: dual but distinct interaction with P-selectin and L1.

P. Altevogt, M. Sammar, S. Aigner, 1997, Biochimica et biophysica acta.

HSP90α induces immunosuppressive myeloid cells in melanoma via TLR4 signaling

Ihor O. Arkhypov, J. Utikal, P. Altevogt, 2022, Journal for ImmunoTherapy of Cancer.

The cell adhesion molecule L1: species- and cell-type-dependent multiple binding mechanisms.

P. Altevogt, G. Kadmon, 1997, Differentiation; research in biological diversity.

Microenvironment and Immunology Metalloprotease-Mediated Tumor Cell Shedding of B 7-H 6 , the Ligand of the Natural Killer Cell – Activating Receptor NKp 30

P. Altevogt, S. Rose-John, Sonja Textor, 2014 .

Characterization of the L1-Neurocan-binding Site

P. Altevogt, P. Gutwein, U. Rauch, 2000, The Journal of Biological Chemistry.

Expression of CD24 and Siglec-10 in first trimester placenta: implications for immune tolerance at the fetal–maternal interface

P. Altevogt, B. Huppertz, H. Meiri, 2017, Histochemistry and Cell Biology.

Combined targeting of TGF-β1 and integrin β3 impairs lymph node metastasis in a mouse model of non-small-cell lung cancer

P. Altevogt, R. Peláez, Xabier Morales, 2014, Molecular Cancer.

Booster dose of mRNA vaccine augments waning T cell and antibody responses against SARS-CoV-2

Ihor O. Arkhypov, J. Utikal, P. Altevogt, 2022, Frontiers in Immunology.

Heat‐stable antigen/CD24 on mouse T lymphocytes: evidence for a costimulatory function

P. Altevogt, Marcus Hubbe, M. Hubbe, 1994, European journal of immunology.

Expression and function of the neural cell adhesion molecule L1 in mouse leukocytes

P. Altevogt, M. Schachner, V. Schirrmacher, 1992, European journal of immunology.

Endogenous retroviral env genes after N-methyl-N'-nitro-N-nitrosoguanidine treatment of mouse tumor cells: stable DNA amplification and rearrangement.

P. Altevogt, D. Apt, J. Schreck, 1989, Cancer research.

CD24 affects CXCR4 function in pre-B lymphocytes and breast carcinoma cells

Peter Altevogt, P. Altevogt, Heidi Schabath, 2006, Journal of Cell Science.

Lack of CD24 expression in mice reduces the number of leukocytes in the colon.

P. Altevogt, L. Boon, N. Arber, 2014, Immunology letters.

Antibody targeting of CD24 efficiently retards growth and influences cytokine milieu in experimental carcinomas

T. Schlange, P. Altevogt, I. Herr, 2013, British Journal of Cancer.

Differential, LFA-1-sensitive effects of antibodies to nectadrin, the heat-stable antigen, on B lymphoblast aggregation and signal transduction.

P. Altevogt, M. Schachner, G. Kadmon, 1994, Biochemical and biophysical research communications.

L1 adhesion molecule on mouse leukocytes: regulation and involvement in endothelial cell binding

P. Altevogt, M. Hubbe, M. Schachner, 1993, European journal of immunology.

Adhesive Hierarchy of the Cell Adhesion Molecules L1, CD24, and α6 Integrin in Murine Neuroblastoma N2A Cells

P. Altevogt, M. Schachner, B. Imhof, 1995 .

Anti-CD2 antibodies induce T cell unresponsiveness in vivo

P. Altevogt, C. Berek, B. Kyewski, 1991, The Journal of experimental medicine.

Resistance of metastatic tumor variants to tumor-specific cytotoxic T-lymphocytes not due to defects in expression of restricting major histocompatibility complex molecules in murine cells.

P. Altevogt, S. Leidig, B. Heckl-Oestreicher, 1984, Cancer research.

The RGD integrin binding site in human L1-CAM is important for nuclear signaling.

P. Altevogt, D. Gast, H. Schäfer, 2008, Experimental cell research.

Long‐term Maintenance of HLA‐D Restricted T Cells Specific for Soluble Antigens

P. Altevogt, H. Wigzell, J. Kurnick, 1980, Scandinavian journal of immunology.

L1-CAM in a membrane-bound or soluble form augments protection from apoptosis in ovarian carcinoma cells.

P. Altevogt, P. Gutwein, D. Gast, 2007, Gynecologic oncology.

Antibody 12‐15 cross‐reacts with mouse Feγ receptors and CD2: study of thymus expression, genetic polymorphism and biosynthesis of the CD2 protein

P. Altevogt, V. Schirrmacher, P. Hoegen, 1989, European journal of immunology.

Adhesion molecules CD171 (L1CAM) and CD24 are expressed by primary neuroendocrine carcinomas of the skin (Merkel cell carcinomas)

H. Kurzen, P. Altevogt, U. Egner, 2003, Journal of cutaneous pathology.

Structural basis for altered soybean agglutinin lectin binding between a murine metastatic lymphoma and an adhesive low malignant variant.

P. Altevogt, R. Brossmer, V. Schirrmacher, 1987, Experimental cell research.

Critical amino acid residues of the α4 subunit for α4β7 integrin function

P. Altevogt, Y. Zeller, S. Mechtersheimer, 2001 .

A Role for Cell Surface Sialic Acid in Liberating Metastatic Tumor Cells from Host Control

J. Dennis, P. Altevogt, V. Schirrmacher, 1986 .

A mouse hepatocyte carbohydrate‐specific receptor and its interaction with liver‐metastasizing tumor cells

P. Altevogt, V. Schirrmacher, P. Robinson, 1983, International journal of cancer.

Identical forms of the CD2 antigen expressed by mouse T and B lymphocytes

P. Altevogt, B. Kyewski, M. Michaelis, 1989, European journal of immunology.

Antibody therapy to human L1CAM in a transgenic mouse model blocks local tumor growth but induces EMT

P. Altevogt, U. Haberkorn, M. Mittelbronn, 2015, International journal of cancer.

L1CAM expression in endometrial carcinomas is regulated by usage of two different promoter regions

P. Altevogt, C. Geismann, S. Sebens, 2010, BMC Molecular Biology.

Extracellular vesicles from human saliva promote hemostasis by delivering coagulant tissue factor to activated platelets

Elmar L. Gool, C. Maas, P. Altevogt, 2018, Journal of thrombosis and haemostasis : JTH.

Effects of mutagens on the immunogenicity of tumor cells: comparison of cell surface changes induced by 5-azacytidine and N-methyl-N'-nitro-N-nitrosoguanidine.

P. Altevogt, 1986, Cancer research.

The L1 Adhesion Molecule Supports αvβ3-Mediated Migration of Human Tumor Cells and Activated T Lymphocytes

P. Altevogt, R. Schwartz-Albiez, S. Katich, 1997 .

Nectadrin, the heat-stable antigen, is a cell adhesion molecule

P. Altevogt, M. Schachner, M. Sammar, 1992, The Journal of cell biology.

Expression of L1 cell adhesion molecule is associated with lymphoma growth and metastasis

P. Altevogt, M. Hubbe, H. Verschueren, 1993, Clinical & Experimental Metastasis.

L1 Makes Immunological Progress by Expanding Its Relations

P. Altevogt, A. Montgomery, G. Kadmon, 1998, Developmental immunology.

Evidence for Cis Interaction and Cooperative Signalling by the Heat‐stable Antigen Nectadrin (murine CD24) and the Cell Adhesion Molecule L1 in Neurons

P. Altevogt, M. Schachner, R. Horstkorte, 1995, The European journal of neuroscience.

Role of L1 cell adhesion molecule (L1CAM) in the metastatic cascade: promotion of dissemination, colonization, and metastatic growth

P. Altevogt, A. Krüger, S. Sebens, 2013, Clinical & Experimental Metastasis.

Elevated L1CAM expression in precursor lesions and primary and metastastic tissues of pancreatic ductal adenocarcinoma.

P. Altevogt, B. Sipos, G. Klöppel, 2010, Oncology reports.

Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression

J. Utikal, P. Altevogt, V. Umansky, 2018, Front. Immunol..

High-frequency generation of altered Mr 70,000 env glycoproteins in N-methyl-N'-nitro-N-nitrosoguanidine-treated murine tumor cells.

P. Altevogt, D. Apt, 1988, Cancer research.

Spontaneous Phenotypic Shifts from Low to High Metastatic Capacity

P. Altevogt, V. Schirrmacher, K. Bosslet, 1983 .

A rapid method for the isolation of metastasizing tumour cells from internal organs with the help of isopycnic density-gradient centrifugation in Percoll.

P. Altevogt, V. Schirrmacher, K. Bosslet, 1981, British Journal of Cancer.

Antigenic variation in cancer metastasis: immune escape versus immune control

P. Altevogt, V. Schirrmacher, K. Bosslet, 2004, Cancer and Metastasis Reviews.

Different expression levels of alpha3/4 fucosyltransferases and Lewis determinants in ovarian carcinoma tissues and cell lines.

P. Altevogt, C. Reis, A. Stoeck, 2006, International journal of oncology.

Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression

J. Utikal, P. Altevogt, V. Umansky, 2018, British Journal of Cancer.

Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors

J. Utikal, P. Altevogt, V. Umansky, 2018, Front. Immunol..

Myeloid-derived suppressor cells and tumor escape from immune surveillance

J. Utikal, P. Altevogt, V. Umansky, 2017, Seminars in Immunopathology.

Interaction and uptake of exosomes by ovarian cancer cells

Sascha Keller, Peter Altevogt, P. Altevogt, 2011, BMC Cancer.

Perspective – Escape from destruction: how cancer-derived EVs are protected from phagocytosis

J. Utikal, P. Altevogt, L. Hüser, 2020 .

Novel insights into the function of CD24: A driving force in cancer

G. Kristiansen, P. Altevogt, L. Hüser, 2020, International journal of cancer.

SOX2 in development and cancer biology.

J. Utikal, P. Altevogt, L. Hüser, 2020, Seminars in cancer biology.

The cytoplasmic part of L1-CAM controls growth and gene expression in human tumors that is reversed by therapeutic antibodies

P. Altevogt, A. Krüger, D. Gast, 2007, Oncogene.

Molecular identification of lectin binding sites differentiating related low and high metastatic murine lymphomas

P. Altevogt, V. Schirrmacher, E. Lang, 2005, Clinical & Experimental Metastasis.

The CD24/P-selectin binding pathway initiates lung arrest of human A125 adenocarcinoma cells.

P. Altevogt, K. Ley, A. Hafezi-Moghadam, 2000, Cancer research.

L1CAM

P. Altevogt, Uwe Schirmer, S. Bondong, 2012, Cell adhesion & migration.

L1 Is Sequentially Processed by Two Differently Activated Metalloproteases and Presenilin/γ-Secretase and Regulates Neural Cell Adhesion, Cell Migration, and Neurite Outgrowth

C. Blobel, P. Altevogt, S. Rose-John, 2005, Molecular and Cellular Biology.

L1, a novel target of β-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers

P. Altevogt, A. Ben-Ze'ev, T. Brabletz, 2005, The Journal of cell biology.

L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomas

P. Altevogt, L. Edler, P. Gutwein, 2003, The Lancet.

ADAM10‐mediated cleavage of L1 adhesion molecule at the cell surface and in released membrane vesicles

P. Altevogt, H. Zentgraf, P. Gutwein, 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Ectodomain shedding of L1 adhesion molecule promotes cell migration by autocrine binding to integrins

P. Altevogt, F. Fahrenholz, N. Agmon-Levin, 2001, The Journal of cell biology.

Integrin and Neurocan Binding to L1 Involves Distinct Ig Domains*

P. Altevogt, U. Rauch, S. Beer, 1999, The Journal of Biological Chemistry.

The L1 adhesion molecule supports alpha v beta 3-mediated migration of human tumor cells and activated T lymphocytes.

P. Altevogt, R. Schwartz-Albiez, S. Katich, 1997, Biochemical and Biophysical Research Communications - BBRC.

L1 adhesion molecule on human lymphocytes and monocytes: expression and involvement in binding to αvβ3 integrin

P. Altevogt, P. Möller, J. Kemshead, 1996 .

The L1 adhesion molecule is a cellular ligand for VLA-5

P. Altevogt, M. Hubbe, H. Yagita, 1995, Journal of Cell Biology.

Extracellular vesicle-mediated transfer of functional RNA in the tumor microenvironment

P. Altevogt, K. Plate, H. Sültmann, 2015, Oncoimmunology.

miR-449a Repression Leads to Enhanced NOTCH Signaling in TMPRSS2:ERG Fusion Positive Prostate Cancer Cells

S. Klauck, G. Kristiansen, P. Altevogt, 2021, Cancers.

Genetic determination of antibody specificity

P. Altevogt, N. Hilschmann, M. Engelhard, 1978, Naturwissenschaften.

Brain development in mice lacking L1–L1 homophilic adhesion

P. Altevogt, H. Kamiguchi, V. Lemmon, 2004, The Journal of cell biology.

IL-6 as a major regulator of MDSC activity and possible target for cancer immunotherapy.

Ihor O. Arkhypov, J. Utikal, P. Altevogt, 2020, Cellular immunology.

Inhibition of cell proliferation, adhesion, and invasion with an anti-L1-cell adhesion molecule monoclonal antibody in an in vitro endometriosis model.

P. Altevogt, A. Starzinski-Powitz, D. Hornung, 2010, Fertility and sterility.

Evaluating L1CAM expression in human endometrial cancer using qRT-PCR

P. Altevogt, H. Fiegl, C. Marth, 2016, Oncotarget.

Prognostic significance of L1CAM in ovarian cancer and its role in constitutive NF-κB activation.

P. Altevogt, R. Zeillinger, T. Hielscher, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

L1CAM–integrin interaction induces constitutive NF-κB activation in pancreatic adenocarcinoma cells by enhancing IL-1β expression

P. Altevogt, A. Arlt, S. Bondong, 2010, Oncogene.

ADAM10 is upregulated in melanoma metastasis compared with primary melanoma.

P. Altevogt, R. Dummer, J. Reichrath, 2010, The Journal of investigative dermatology.

L1 (CD171) as a novel biomarker for ovarian and endometrial carcinomas

P. Altevogt, M. Huszar, M. Fogel, 2004, Expert review of molecular diagnostics.

Role of Src Kinases in the ADAM-mediated Release of L1 Adhesion Molecule from Human Tumor Cells*

P. Altevogt, N. Agmon-Levin, P. Gutwein, 2000, The Journal of Biological Chemistry.

Functional cooperation between the neural adhesion molecules L1 and N- CAM is carbohydrate dependent

P. Altevogt, M. Schachner, A. Kowitz, 1990, The Journal of cell biology.

The neural cell adhesion molecule N-CAM enhances L1-dependent cell-cell interactions

P. Altevogt, M. Schachner, A. Kowitz, 1990, The Journal of cell biology.

Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma

L. Mariani, P. Altevogt, V. Bollati, 2018, The Journal of clinical investigation.

Targeting SOX2 in anticancer therapy

J. Utikal, P. Altevogt, L. Hüser, 2018, Expert opinion on therapeutic targets.

Melanoma extracellular vesicles generate immunosuppressive myeloid cells by PD-L1 upregulation via TLR4 signaling.

J. Utikal, P. Altevogt, L. Hüser, 2019, Cancer research.

Body fluid derived exosomes as a novel template for clinical diagnostics

P. Altevogt, S. Keller, Anne-kathleen Rupp, 2011, Journal of Translational Medicine.

Loss of EpCAM expression in breast cancer derived serum exosomes: role of proteolytic cleavage.

Holger Sültmann, Gerhard Moldenhauer, Sascha Keller, 2011, Gynecologic oncology.

TMPRSS2:ERG gene fusion variants induce TGF-β signaling and epithelial to mesenchymal transition in human prostate cancer cells

S. Klauck, P. Altevogt, H. Sültmann, 2017, Oncotarget.

SOX2‐mediated upregulation of CD24 promotes adaptive resistance toward targeted therapy in melanoma

J. Utikal, P. Altevogt, L. Hüser, 2018, International journal of cancer.

Identification and Characterization of Tumor-Initiating Cells in Multiple Myeloma.

F. Zhan, P. Altevogt, M. Tomasson, 2019, Journal of the National Cancer Institute.

Concanavalin A-induced interferon gamma production by murine spleen cells and T cell lines. Lack of correlation with Lyt 1,2 phenotype.

B. Klein, P. Altevogt, F. Marcucci, 1984, Immunobiology.

E2F3a is critically involved in epidermal growth factor receptor-directed proliferation in ovarian cancer.

P. Altevogt, S. Skvortsov, H. Fiegl, 2010, Cancer research.

CD24 is a marker of exosomes secreted into urine and amniotic fluid.

P. Altevogt, P. Gutwein, M. Abdel-Bakky, 2007, Kidney international.

Evidence for secretion of Cu,Zn superoxide dismutase via exosomes from a cell model of amyotrophic lateral sclerosis

P. Altevogt, S. Keller, Júlia Costa, 2007, Neuroscience Letters.

Nuclear translocation and signalling of L1-CAM in human carcinoma cells requires ADAM10 and presenilin/γ-secretase activity

P. Altevogt, P. Gutwein, D. Gast, 2009, The Biochemical journal.

Cleavage of L1 in Exosomes and Apoptotic Membrane Vesicles Released from Ovarian Carcinoma Cells

P. Altevogt, O. Linderkamp, T. Condon, 2005, Clinical Cancer Research.

Metalloprotease-mediated tumor cell shedding of B7-H6, the ligand of the natural killer cell-activating receptor NKp30.

P. Altevogt, S. Rose-John, Sonja Textor, 2014, Cancer research.

Novel insights into exosome-induced, tumor-associated inflammation and immunomodulation.

J. Utikal, P. Altevogt, V. Umansky, 2014, Seminars in cancer biology.

Influence of L1-CAM expression of breast cancer cells on adhesion to endothelial cells

P. Altevogt, U. Schumacher, F. Jänicke, 2012, Journal of Cancer Research and Clinical Oncology.

Targeting CD24 for treatment of colorectal and pancreatic cancer by monoclonal antibodies or small interfering RNA.

Peter Altevogt, Alex Starr, Nadir Arber, 2008, Cancer research.

Cancer by Monoclonal Antibodies or Small Interfering RNA Targeting CD 24 for Treatment of Colorectal and Pancreatic

P. Altevogt, N. Arber, T. Wang, 2008 .

Targeting CD 24 for Treatment of Colorectal and Pancreatic Cancer by Monoclonal Antibodies or Small Interfering RNA

P. Altevogt, N. Arber, T. Wang, 2008 .

Role of miR-34a as a suppressor of L1CAM in endometrial carcinoma

P. Altevogt, H. Sültmann, R. Zeillinger, 2014, Oncotarget.

Modern Aspects of Immunotherapy with Checkpoint Inhibitors in Melanoma

Ihor O. Arkhypov, J. Utikal, P. Altevogt, 2020, International journal of molecular sciences.

Myeloid Cell Modulation by Tumor-Derived Extracellular Vesicles

Ihor O. Arkhypov, J. Utikal, P. Altevogt, 2020, International journal of molecular sciences.

[The primary structure of a monoclonal IgA-immunoglobulin (IgA Tro.), II. The amino acid sequence of the H-chain, alpha-type, subgroup III; structure of the complete IgA-molecule (author's transl)].

P. Altevogt, N. Hilschmann, A. Kortt, 1975, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.

Myofibroblast-induced tumorigenicity of pancreatic ductal epithelial cells is L1CAM dependent.

P. Altevogt, H. Kalthoff, C. Geismann, 2012, Carcinogenesis.

Up-regulation of L1CAM in pancreatic duct cells is transforming growth factor beta1- and slug-dependent: role in malignant transformation of pancreatic cancer.

P. Altevogt, M. Tsao, B. Sipos, 2009, Cancer research.

miR-21-3p is a positive regulator of L1CAM in several human carcinomas.

P. Altevogt, R. Blaheta, H. Fiegl, 2014, Cancer letters.

Binding of the transcription factor Slug to the L1CAM promoter is essential for transforming growth factor-β1 (TGF-β)-induced L1CAM expression in human pancreatic ductal adenocarcinoma cells.

P. Altevogt, C. Geismann, A. Arlt, 2010, International journal of oncology.

Contractile Forces Contribute to Increased Glycosylphosphatidylinositol-anchored Receptor CD24-facilitated Cancer Cell Invasion*

P. Altevogt, C. Mierke, N. Bretz, 2011, The Journal of Biological Chemistry.

Generation of adhesive tumor variants: Chromosomal changes, reduction in malignancy and increased expression of a distinct membrane glycoprotein

P. Altevogt, V. Schirrmacher, R. Benke, 1988, Clinical & Experimental Metastasis.

Tumoural CXCL16 expression is a novel prognostic marker of longer survival times in renal cell cancer patients.

G. Kristiansen, P. Altevogt, K. Jung, 2009, European journal of cancer.

Fibroblast growth factor receptor 4 gene (FGFR4) 388Arg allele predicts prolonged survival and platinum sensitivity in advanced ovarian cancer

A. Schneeweiss, P. Altevogt, C. Sohn, 2012, International journal of cancer.

Fallopian tube precursor lesions of serous ovarian carcinoma require L1CAM for dissemination and metastasis

G. Mills, P. Altevogt, R. Drapkin, 2018, bioRxiv.

Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM.

G. Kristiansen, P. Altevogt, J. Sehouli, 2007, Gynecologic oncology.

Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer

A. Schneeweiss, P. Altevogt, F. Marmé, 2017, BMC Cancer.

Redirected T cells that target pancreatic adenocarcinoma antigens eliminate tumors and metastases in mice.

P. Altevogt, Z. Eshhar, H. Abken, 2012, Gastroenterology.

IL-6 regulates CCR5 expression and immunosuppressive capacity of MDSC in murine melanoma

J. Utikal, P. Altevogt, L. Hüser, 2020, Journal for ImmunoTherapy of Cancer.

Combined treatment of L1CAM antibodies and cytostatic drugs improve the therapeutic response of pancreatic and ovarian carcinoma.

P. Altevogt, A. Krüger, S. Sebens, 2012, Cancer letters.

L1CAM protein expression is associated with poor prognosis in non-small cell lung cancer

G. Kristiansen, P. Altevogt, H. Moch, 2011, Molecular Cancer.

Therapeutic antibodies to human L1CAM: functional characterization and application in a mouse model for ovarian carcinoma.

P. Altevogt, J. Endell, Júlia Costa, 2010, Cancer research.

Elevated L 1 CAM expression in precursor lesions and primary and metastastic tissues of pancreatic ductal adenocarcinoma

P. Altevogt, B. Sipos, G. Klöppel, 2010 .

Clinical and mechanistic aspects of glucocorticoid-induced chemotherapy resistance in the majority of solid tumors

H. Friess, H. Dienemann, P. Altevogt, 2007, Cancer biology & therapy.

Membranous CD24 expression as detected by the monoclonal antibody SWA11 is a prognostic marker in non-small cell lung cancer patients

G. Kristiansen, P. Altevogt, L. Heukamp, 2015, BMC Clinical Pathology.

CD24 mediates rolling of breast carcinoma cells on P‐selectin

Klaus Ley, Peter Altevogt, P. Altevogt, 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

CD24 promotes tumor cell invasion by suppressing tissue factor pathway inhibitor-2 (TFPI-2) in a c-Src-dependent fashion

T. Schlange, G. Kristiansen, P. Altevogt, 2011, Clinical & Experimental Metastasis.

L1CAM is required for early dissemination of fallopian tube carcinoma precursors to the ovary

G. Mills, P. Altevogt, P. Kroeger, 2022, Communications biology.

Up‐regulation of L1CAM is linked to loss of hormone receptors and E‐cadherin in aggressive subtypes of endometrial carcinomas

P. Altevogt, C. Marth, E. Müller-Holzner, 2010, The Journal of pathology.

CD24 promotes tumor cell invasion by suppressing tissue factor pathway inhibitor-2 (TFPI-2) in a c-Src-dependent fashion

T. Schlange, G. Kristiansen, P. Altevogt, 2011, Clinical & Experimental Metastasis.

STAT3 inhibitor Napabucasin abrogates MDSC immunosuppressive capacity and prolongs survival of melanoma-bearing mice

J. Utikal, P. Altevogt, C. de la Torre, 2022, Journal for ImmunoTherapy of Cancer.

L1CAM Expression is Related to Non-Endometrioid Histology, and Prognostic for Poor Outcome in Endometrioid Endometrial Carcinoma

P. Altevogt, L. Massuger, J. Pijnenborg, 2016, Pathology & Oncology Research.

A Standardized Staining Protocol for L1CAM on Formalin-Fixed, Paraffin-Embedded Tissues Using Automated Platforms

P. Altevogt, E. Müller-Holzner, A. Zeimet, 2014, The International journal of biological markers.

Helper and suppressor-inducer activity of human T cells and their cloned progeny maintained in long-term culture.

P. Altevogt, J. Kurnick, A. Hayward, 1981, Journal of immunology.

Association of CD2 and CD45 on human T lymphocytes

P. Altevogt, Y. Samstag, S. Meuer, 1990, Nature.

Membranal Cholesterol Is Not Required for L-Selectin Adhesiveness in Primary Lymphocytes but Controls a Chemokine-Induced Destabilization of L-Selectin Rolling Adhesions1

P. Altevogt, R. Alon, P. Gutwein, 2007, The Journal of Immunology.

Abstract P3-06-19: Ki-67 mRNA as a predictor for response to neoadjuvant chemotherapy in primary breast cancer

A. Schneeweiss, P. Altevogt, F. Marmé, 2012 .

Magnetic resonance imaging of melanoma metastases in a clinical relevant human melanoma xenograft scid mouse model.

G. Adam, P. Altevogt, U. Schumacher, 2009, Cancer letters.

Regulation of transcription factor E2F3a and its clinical relevance in ovarian cancer

P. Altevogt, S. Skvortsov, H. Fiegl, 2011, Oncogene.

Role of STAT3 dependent SOX2 and CD24 expression in melanoma cell adaptive resistance towards targeted therapies

J. Utikal, P. Altevogt, L. Hüser, 2019, Oncotarget.

DNA Promoter Methylation and ERG regulate the expression of CD24 in prostate cancer.

S. Klauck, G. Kristiansen, P. Altevogt, 2021, The American journal of pathology.

Tumor promoting capacity of polymorphonuclear myeloid‐derived suppressor cells and their neutralization

J. Utikal, P. Altevogt, V. Umansky, 2021, International journal of cancer.

Modeling Preeclampsia In Vitro: Polymorphic Variants of STOX1-A/B Genes Can Downregulate CD24 in Trophoblast Cell Lines

P. Altevogt, H. Meiri, M. Sammar, 2022, International journal of molecular sciences.

Single-Molecule Localization Microscopy allows for the analysis of cancer metastasis-specific miRNA distribution on the nanoscale

Christoph Cremer, Kerem Can Tezcan, Mathias Hafner, 2015, Oncotarget.

Glycoconjugate profiling of primary melanoma and its sentinel node and distant metastases: implications for diagnosis and pathophysiology of metastases.

P. Altevogt, M. Schachner, U. Schumacher, 2007, Cancer letters.

New antigens presented on tumor cells can cause immune rejection without influencing the frequency of tumor-specific cytolytic T cells.

P. Altevogt, V. Schirrmacher, P. von Hoegen, 1987, Cellular immunology.

CD2: a functional adhesion molecule on murine B cells, involved in interleukin‐4‐induced aggregation

P. Altevogt, E. Severinson, C. Elenström-Magnusson, 1993, European journal of immunology.

The signal transducer CD24 suppresses the germ cell program and promotes an ectodermal rather than mesodermal cell fate in embryonal carcinomas

G. Kristiansen, P. Altevogt, K. Köhrer, 2021, Molecular oncology.

Specifically activated memory T cell subsets from cancer patients recognize and reject xenotransplanted autologous tumors.

P. Altevogt, F. Schuetz, G. Bastert, 2004, The Journal of clinical investigation.

Association of CD2 and T200 (CD45) in mouse T lymphocytes.

P. Altevogt, S. Meuer, B. Schraven, 1990, International immunology.

Murine Fcγ receptor proteins: identification of a previously unrecognized molecule with a monoclonal antibody (12‐15)

P. Altevogt, V. Schirrmacher, H. Kratzin, 1988 .

Anti-CD2 monoclonal antibodies alter cell-mediated immunity in vivo.

P. Altevogt, B. Kyewski, A. Naji, 1991, Transplantation.

N-Glycosylation of total cellular glycoproteins from the human ovarian carcinoma SKOV3 cell line and of recombinantly expressed human erythropoietin.

P. Altevogt, Júlia Costa, H. Conradt, 2011, Glycobiology.

Specifically activated memory T cell subsets from cancer patients recognize and reject xenotransplanted autologous tumors

P. Altevogt, F. Schuetz, G. Bastert, 2004 .

Asp-698 and Asp-811 of the Integrin α4-Subunit Are Critical for the Formation of a Functional Heterodimer*

P. Altevogt, E. Butcher, M. Sammar, 1998, The Journal of Biological Chemistry.

Immunoresistant metastatic tumor variants can re‐express their tumor antigen after treatment with DNA methylation‐inhibiting agents

P. Altevogt, V. Schirrmacher, P. von Hoegen, 1986, International journal of cancer.

The alpha 4 integrin chain is a ligand for alpha 4 beta 7 and alpha 4 beta 1

P. Altevogt, J. Lohr, M. Hubbe, 1995, The Journal of experimental medicine.

CD24 Ala57Val polymorphism predicts pathologic complete response to sequential anthracycline- and taxane-based neoadjuvant chemotherapy for primary breast cancer

A. Schneeweiss, G. Kristiansen, P. Altevogt, 2012, Breast Cancer Research and Treatment.

CD24 induces localization of beta1 integrin to lipid raft domains.

P. Altevogt, B. Fabry, C. Mierke, 2008, Biochemical and biophysical research communications.

Tumor Cell Invasion Is Promoted by Activation of Protease Activated Receptor-1 in Cooperation with the αvβ5 Integrin*

P. Altevogt, R. Bar-Shavit, P. Gutwein, 2001, The Journal of Biological Chemistry.

New plasma membrane proteins expressed by a high metastatic variant of a chemically induced tumor.

P. Altevogt, V. Schirrmacher, 1984, European journal of cancer & clinical oncology.

Heat-stable antigen (CD24) as ligand for mouse P-selectin.

P. Altevogt, M. Hubbe, M. Schachner, 1994, International immunology.

CD24 controls Src/STAT3 activity in human tumors

T. Schlange, P. Altevogt, C. Mierke, 2012, Cellular and Molecular Life Sciences.

CD24 induces localization of β1 integrin to lipid raft domains

P. Altevogt, B. Fabry, C. Mierke, 2008 .

Exosomes from human ovarian carcinoma SKOV3 cells are enriched in glycosylated proteins

P. Altevogt, Júlia Costa, C. Escrevente, 2010, BMC Proceedings.

CD24 is a marker for human breast carcinoma.

P. Altevogt, J. Friederichs, L. Roitman, 1999, Cancer letters.

CD24, a mucin-type glycoprotein, is a ligand for P-selectin on human tumor cells.

P. Altevogt, R. Stahel, D. Vestweber, 1997, Blood.

Expression and promotor hypermethylation of miR-34a in the various histological subtypes of ovarian cancer

P. Altevogt, H. Fiegl, N. Concin, 2016, BMC Cancer.

Extracellular Vesicles from Ovarian Carcinoma Cells Display Specific Glycosignatures

Sofia B. Carvalho, Sofia B Carvalho, P. Altevogt, 2015, Biomolecules.

Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes.

P. Altevogt, F. Marmé, J. Sehouli, 2009, Cancer letters.

HER3-Receptor-Mediated STAT3 Activation Plays a Central Role in Adaptive Resistance toward Vemurafenib in Melanoma

Ihor O. Arkhypov, J. Utikal, P. Altevogt, 2020, Cancers.

Body Fluid Exosomes Promote Secretion of Inflammatory Cytokines in Monocytic Cells via Toll-like Receptor Signaling*

P. Altevogt, F. Marmé, L. Umansky, 2013, The Journal of Biological Chemistry.

, Johannes Ridinger , via Toll-like Receptor Signaling CellsInflammatory Cytokines in Monocytic Body Fluid Exosomes Promote Secretion of Signal Transduction

P. Altevogt, F. Marmé, L. Umansky, 2013 .

Molecular and clinical dissection of CD24 antibody specificity by a comprehensive comparative analysis

G. Kristiansen, K. Winzer, P. Altevogt, 2010, Laboratory Investigation.

Sulforaphane targets pancreatic tumour-initiating cells by NF-κB-induced antiapoptotic signalling

P. Altevogt, A. Kolb, M. Büchler, 2008, Gut.

Role of L1 cell adhesion molecule (L1CAM) in the metastatic cascade: promotion of dissemination, colonization, and metastatic growth

P. Altevogt, A. Krüger, S. Sebens, 2013, Clinical & Experimental Metastasis.

Functional role of N-glycosylation from ADAM10 in processing, localization and activity of the enzyme.

P. Altevogt, C. Soares, V. Morais, 2008, Biochimica et biophysica acta.

Involves Two Distinct Mechanisms Dendritic Cells upon CD4+ T Cell Priming Transfer of T Cell Surface Molecules to

Percy A. Knolle, Sascha Keller, Peter Altevogt, 2013 .

Integrin Leukocyte Function-associated Antigen-1-mediated Cell Binding Can Be Activated by Clustering of Membrane Rafts*

P. Altevogt, Kerstin Krauss, 1999, The Journal of Biological Chemistry.

L 1-CAM is commonly expressed in testicular germ cell tumours

P. Altevogt, H. Moch, T. Hermanns, 2017 .

L1-CAM is commonly expressed in testicular germ cell tumours

P. Altevogt, H. Moch, T. Hermanns, 2016, Journal of Clinical Pathology.

Generation of novel, secreted epidermal growth factor receptor (EGFR/ErbB1) isoforms via metalloprotease‐dependent ectodomain shedding and exosome secretion

P. Altevogt, P. Dempsey, A. Alonso, 2008, Journal of cellular biochemistry.

Downregulation of junctional adhesion molecule-A is involved in the progression of clear cell renal cell carcinoma.

G. Kristiansen, P. Altevogt, H. Moch, 2009, Biochemical and biophysical research communications.

Linking L1CAM-mediated signaling to NF-κB activation.

Marco Pfeifer, Peter Altevogt, Helena Kiefel, 2011, Trends in molecular medicine.

L1CAM is expressed in triple-negative breast cancers and is inversely correlated with Androgen receptor

P. Altevogt, E. Müller-Holzner, A. Zeimet, 2014, BMC Cancer.

Blocking Migration of Polymorphonuclear Myeloid-Derived Suppressor Cells Inhibits Mouse Melanoma Progression

Ihor O. Arkhypov, J. Utikal, H. Augustin, 2021, Cancers.

L1 augments cell migration and tumor growth but not β3 integrin expression in ovarian carcinomas

P. Altevogt, I. Herr, T. Wenger, 2005, International journal of cancer.

EMT-associated up-regulation of L1CAM provides insights into L1CAM-mediated integrin signalling and NF-κB activation.

P. Altevogt, S. Sebens, Uwe Schirmer, 2012, Carcinogenesis.

Truncated isoform Vav3.1 is highly expressed in ovarian cancer stem cells and clinically relevant in predicting prognosis and platinum‐response

P. Altevogt, H. Hackl, W. Parson, 2018, International journal of cancer.

Prevention of metastatic spread by postoperative immunotherapy with virally modified autologous tumor cells. III. Postoperative activation of tumor-specific CTLP from mice with metastases requires stimulation with the specific antigen plus additional signals.

P. Altevogt, R. Heicappell, V. Schirrmacher, 1989, Invasion and Metastasis.

Adhesive function of newcastle-disease virus hemagglutinin in tumor-host interaction.

P. Altevogt, M. Hubbe, V. Schirrmacher, 1995, International journal of oncology.

Detection of Tumour‐Associated Transplantation Antigens by Syngeneic Cytotoxic T Lymphocytes after Fusion of Tumour Cell Membrane Vesicles to Recipient Cells

P. Altevogt, 1984, Scandinavian journal of immunology.

Heat stable antigen (mouse CD24) supports myeloid cell binding to endothelial and platelet P-selectin.

P. Altevogt, M. Hubbe, E. Butcher, 1995, International immunology.

CD 24 Expression Is a New Prognostic Marker in Breast Cancer

C. Pilarsky, G. Kristiansen, K. Winzer, 2003 .

Exosomes as a potential tool for a specific delivery of functional molecules.

P. Altevogt, I. Nazarenko, Anne-kathleen Rupp, 2013, Methods in molecular biology.

L1CAM promotes enrichment of immunosuppressive T cells in human pancreatic cancer correlating with malignant progression

P. Altevogt, U. Schumacher, M. Ebsen, 2014, Molecular oncology.

Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer

A. Schneeweiss, P. Altevogt, F. Marmé, 2017, BMC Cancer.

L1CAM in the Early Enteric and Urogenital System

P. Altevogt, N. Concin, M. Zwierzina, 2017, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Antibodies directed against L1-CAM synergize with Genistein in inhibiting growth and survival pathways in SKOV3ip human ovarian cancer cells.

P. Altevogt, P. Schubiger, Susan Cohrs, 2008, Cancer letters.

Unexpected H-2 antigen expression by mouse tumor cells, a cautionary note

P. Altevogt, F. Garrido, V. Schirrmacher, 2004, Immunogenetics.

Change in metastasis and organotropism of mouse lymphoma variants associated with changes in expression of adhesion molecules and chemotactic responsiveness

P. Altevogt, V. Schirrmacher, R. Benke, 1991 .

Reduced Placental CD24 in Preterm Preeclampsia Is an Indicator for a Failure of Immune Tolerance

P. Altevogt, B. Huppertz, H. Meiri, 2021, International journal of molecular sciences.

Disrupted Schwann cell–axon interactions in peripheral nerves of mice with altered L1-integrin interactions

P. Altevogt, H. Kamiguchi, V. Lemmon, 2005, Molecular and Cellular Neuroscience.

Secretogranin II influences the assembly and function of MHC class I in melanoma

J. Utikal, P. Altevogt, R. Offringa, 2023, Experimental Hematology & Oncology.

L1 Cell Adhesion Molecule as a Potential Therapeutic Target in Murine Models of Endometriosis Using a Monoclonal Antibody Approach

P. Altevogt, P. Hunold, D. Hornung, 2013, PloS one.

The Role of L1 in the Progression of Ovarian Carcinomas

P. Altevogt, M. Fogel, 2004, Zentralblatt fur Gynakologie.

Evolutionary Origin of Antibody Specificity

P. Altevogt, N. Hilschmann, M. Engelhard, 1976 .